ExeVir Bio Company
ExeVir Bio is a Belgium-based company that develops single-domain antibody-based therapies that help patients ward off viral infections.
Technology:
Drug Delivery
Industry:
PharmTech
Headquarters:
Zwijnaarde, Oost-Vlaanderen, Belgium
Founded Date:
2020
Employees Number:
1-10
Funding Status:
Early Stage Venture
Estimated Revenue:
$1B to $10B
Register and Claim Ownership